Oxymetazoline (HCl) Overview Categories 21 Ophthalmological preparations21.6 Non-specific anticonjunctivitis preparations 25 Drugs acting on the respiratory tract25.4 Nasal preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Miltefosine Manufacturers of Miltefosine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Miltefosine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.09 %0.09 (0.09)12 hourlyIntra Nasal1-2 drops in each nostril.0.025 %0.025 (0.025)As recommended.Ophthalmicdrops Paedriatic Dosage (20kg) 0.025 to 0.035 mg0.03 (0.03)12 hourlyNasalFor children above 5 yrs. Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Miltefosine Back to top Manufacturers of Oxymetazoline (HCl) in Pakistan Barrett Epla Scotmann Back to top Previous Drug Generic - Next Drug Generic
Oxymetazoline (HCl) Overview Categories 21 Ophthalmological preparations21.6 Non-specific anticonjunctivitis preparations 25 Drugs acting on the respiratory tract25.4 Nasal preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Miltefosine Manufacturers of Miltefosine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Miltefosine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.09 %0.09 (0.09)12 hourlyIntra Nasal1-2 drops in each nostril.0.025 %0.025 (0.025)As recommended.Ophthalmicdrops Paedriatic Dosage (20kg) 0.025 to 0.035 mg0.03 (0.03)12 hourlyNasalFor children above 5 yrs. Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Miltefosine Back to top Manufacturers of Oxymetazoline (HCl) in Pakistan Barrett Epla Scotmann Back to top Previous Drug Generic - Next Drug Generic